Scott DL - Search Results

1

Disease activity in rheumatoid arthritis: preliminary report of the Consensus Study Group of the European Workshop for Rheumatology Research.

Scott DL, Panayi GS, van Riel PL, Smolen J, van de Putte LB. Scott DL, et al. Clin Exp Rheumatol. 1992 Sep-Oct;10(5):521-5. Clin Exp Rheumatol. 1992. PMID: 1458708 Review.

2

DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage.

Scott DL, Adebajo AO, el Badaway S, Kirwan J, van de Putte LB, van Riel PL. Scott DL, et al. J Rheumatol Suppl. 1994 Sep;41:36-40. J Rheumatol Suppl. 1994. PMID: 7799383 Review.

3

Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.

Choy EH, Scott DL, Kingsley GH, Williams P, Wojtulewski J, Papasavvas G, Henderson E, Macfarlane D, Erhardt C, Young A, Plant MJ, Panayi GS. Choy EH, et al. Among authors: scott dl. Clin Exp Rheumatol. 2002 May-Jun;20(3):351-8. Clin Exp Rheumatol. 2002. PMID: 12102471 Clinical Trial.

4

Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis.

Gullick NJ, Ibrahim F, Scott IC, Vincent A, Cope AP, Garrood T, Panayi GS, Scott DL, Kirkham BW; TITRATE Programme Investigators. Gullick NJ, et al. Among authors: scott dl, scott ic. BMC Rheumatol. 2019 Feb 25;3:6. doi: 10.1186/s41927-019-0054-y. eCollection 2019. BMC Rheumatol. 2019. PMID: 30886994 Free PMC article.

5

A simple index to assess disease activity in rheumatoid arthritis.

Scott DL. Scott DL. J Rheumatol. 1993 Mar;20(3):582-4. J Rheumatol. 1993. PMID: 8478879

6

Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.

Kalden JR, Scott DL, Smolen JS, Schattenkirchner M, Rozman B, Williams BD, Kvien TK, Jones P, Williams RB, Oed C, Rosenburg R; European Leflunomide Study Group. Kalden JR, et al. Among authors: scott dl. J Rheumatol. 2001 Sep;28(9):1983-91. J Rheumatol. 2001. PMID: 11550964 Clinical Trial.

7

Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.

Scott DL, Smolen JS, Kalden JR, van de Putte LB, Larsen A, Kvien TK, Schattenkirchner M, Nash P, Oed C, Loew-Friedrich I; European Leflunomide Study Group. Scott DL, et al. Ann Rheum Dis. 2001 Oct;60(10):913-23. doi: 10.1136/ard.60.10.913. Ann Rheum Dis. 2001. PMID: 11557646 Free PMC article. Clinical Trial.

8

Control of rheumatoid arthritis by oral tolerance.

Choy EH, Scott DL, Kingsley GH, Thomas S, Murphy AG, Staines N, Panayi GS. Choy EH, et al. Among authors: scott dl. Arthritis Rheum. 2001 Sep;44(9):1993-7. doi: 10.1002/1529-0131(200109)44:9<1993::AID-ART347>3.0.CO;2-A. Arthritis Rheum. 2001. PMID: 11592359 Free article. Clinical Trial.

9

Evaluating biologic agents in rheumatoid arthritis: a framework for clinical trials.

Strand V, Scott DL, Panayi GS. Strand V, et al. Among authors: scott dl. J Rheumatol. 1994 Aug;21(8):1390-2. J Rheumatol. 1994. PMID: 7983635 No abstract available.

10

The clinical value of measuring immunoglobulins when assessing penicillamine therapy in rheumatoid arthritis.

Williams A, Scott DL, Greenwood A, Huskisson EC. Williams A, et al. Among authors: scott dl. Clin Rheumatol. 1988 Sep;7(3):347-53. doi: 10.1007/BF02239191. Clin Rheumatol. 1988. PMID: 3229080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

483 results

Search Page